These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25127461)

  • 1. Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.
    Kim Y; Tae J; Lee K; Rhim H; Choo IH; Cho H; Park WK; Keum G; Choo H
    Bioorg Med Chem; 2014 Sep; 22(17):4587-96. PubMed ID: 25127461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.
    Kim Y; Yeom M; Tae J; Rhim H; Choo H
    Eur J Med Chem; 2016 Mar; 110():302-10. PubMed ID: 26852005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.
    Canale V; Kurczab R; Partyka A; Satała G; Witek J; Jastrzębska-Więsek M; Pawłowski M; Bojarski AJ; Wesołowska A; Zajdel P
    Eur J Med Chem; 2015 Mar; 92():202-11. PubMed ID: 25555143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor.
    Okada M; Matsumoto R; Yamamoto Y; Fukuyama K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular entrance provides selectivity to serotonin 5-HT7 receptor antagonists with antidepressant-like behavior in vivo.
    Medina RA; Vázquez-Villa H; Gómez-Tamayo JC; Benhamú B; Martín-Fontecha M; de la Fuente T; Caltabiano G; Hedlund PB; Pardo L; López-Rodríguez ML
    J Med Chem; 2014 Aug; 57(15):6879-84. PubMed ID: 25073094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
    Kim J; Kim Y; Tae J; Yeom M; Moon B; Huang XP; Roth BL; Lee K; Rhim H; Choo IH; Chong Y; Keum G; Nam G; Choo H
    ChemMedChem; 2013 Nov; 8(11):1855-64. PubMed ID: 24039134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
    Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 5-HT
    Canale V; Partyka A; Kurczab R; Krawczyk M; Kos T; Satała G; Kubica B; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Popik P; Zajdel P
    Bioorg Med Chem; 2017 May; 25(10):2789-2799. PubMed ID: 28391970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.
    Canale V; Kurczab R; Partyka A; Satała G; Lenda T; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Zajdel P
    Eur J Med Chem; 2016 Jan; 108():334-346. PubMed ID: 26698537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel quinazolinone derivatives as 5-HT7 receptor ligands.
    Na YH; Hong SH; Lee JH; Park WK; Baek DJ; Koh HY; Cho YS; Choo H; Pae AN
    Bioorg Med Chem; 2008 Mar; 16(5):2570-8. PubMed ID: 18083580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
    Wesołowska A; Nikiforuk A; Stachowicz K
    Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.
    Wang R; Xu Y; Wu HL; Li YB; Li YH; Guo JB; Li XJ
    Eur J Pharmacol; 2008 Jan; 578(1):43-50. PubMed ID: 17942093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation.
    Kucwaj-Brysz K; Warszycki D; Podlewska S; Witek J; Witek K; González Izquierdo A; Satała G; Loza MI; Lubelska A; Latacz G; Bojarski AJ; Castro M; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2016 Apr; 112():258-269. PubMed ID: 26900658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity.
    Kim Y; Park H; Lee J; Tae J; Kim HJ; Min SJ; Rhim H; Choo H
    Eur J Med Chem; 2016 Nov; 123():180-190. PubMed ID: 27475109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of aryl-biphenyl-2-ylmethylpiperazines as novel scaffolds for 5-HT(7) ligands and role of the aromatic substituents in binding to the target receptor.
    Kim Y; Kim J; Tae J; Roth BL; Rhim H; Keum G; Nam G; Choo H
    Bioorg Med Chem; 2013 May; 21(9):2568-76. PubMed ID: 23541835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.
    Kassai F; Schlumberger C; Kedves R; Pietraszek M; Jatzke C; Lendvai B; Gyertyán I; Danysz W
    Behav Pharmacol; 2012 Aug; 23(4):397-406. PubMed ID: 22785385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
    Yi LT; Xu HL; Feng J; Zhan X; Zhou LP; Cui CC
    Physiol Behav; 2011 Jan; 102(1):1-6. PubMed ID: 20951716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.